Clinical Trials Directory

Trials / Completed

CompletedNCT02392403

Clinical Investigation of the Nucleus® CI532 Cochlear Implant

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Cochlear · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate the clinical benefit for patients implanted with the Nucleus® CI532 cochlear implant and to demonstrate the atraumatic nature of the electrode design. Nucleus® CI532 has a pre-curved, perimodiolar array, the EA32, which is introduced into the cochlea through a straightening sheath.

Conditions

Interventions

TypeNameDescription
DEVICENucleus CI532 cochlear implant

Timeline

Start date
2015-04-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2015-03-19
Last updated
2018-11-01
Results posted
2018-11-01

Locations

8 sites across 4 countries: Australia, France, Germany, Spain

Source: ClinicalTrials.gov record NCT02392403. Inclusion in this directory is not an endorsement.

Clinical Investigation of the Nucleus® CI532 Cochlear Implant (NCT02392403) · Clinical Trials Directory